GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Epsilon Healthcare Ltd (FRA:9TH0) » Definitions » EPS (Diluted)

Epsilon Healthcare (FRA:9TH0) EPS (Diluted) : €-0.01 (TTM As of Jun. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Epsilon Healthcare EPS (Diluted)?

Epsilon Healthcare's Earnings per Share (Diluted) for the six months ended in Jun. 2023 was €-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.01.

Epsilon Healthcare's EPS (Basic) for the six months ended in Jun. 2023 was €-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.01.

Epsilon Healthcare's EPS without NRI for the six months ended in Jun. 2023 was €-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.01.

During the past 3 years, the average EPS without NRIGrowth Rate was 25.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Epsilon Healthcare's highest 3-Year average EPS without NRI Growth Rate was 25.10% per year. The lowest was -30.10% per year. And the median was 15.70% per year.


Epsilon Healthcare EPS (Diluted) Historical Data

The historical data trend for Epsilon Healthcare's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epsilon Healthcare EPS (Diluted) Chart

Epsilon Healthcare Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EPS (Diluted)
Get a 7-Day Free Trial -0.04 -0.06 -0.04 -0.03 -0.03

Epsilon Healthcare Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.02 -0.02 -0.01 -

Competitive Comparison of Epsilon Healthcare's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Epsilon Healthcare's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epsilon Healthcare's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Epsilon Healthcare's PE Ratio distribution charts can be found below:

* The bar in red indicates where Epsilon Healthcare's PE Ratio falls into.



Epsilon Healthcare EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Epsilon Healthcare's Diluted EPS for the fiscal year that ended in Dec. 2022 is calculated as

Diluted EPS (A: Dec. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-8.465-0)/300.354
=-0.03

Epsilon Healthcare's Diluted EPS for the quarter that ended in Jun. 2023 is calculated as

Diluted EPS (Q: Jun. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.444-0)/298.798
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epsilon Healthcare  (FRA:9TH0) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Epsilon Healthcare EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Epsilon Healthcare's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Epsilon Healthcare (FRA:9TH0) Business Description

Traded in Other Exchanges
Address
35 Lime Street, Suite 305, Level 3, Sydney, NSW, AUS, 2000
Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.

Epsilon Healthcare (FRA:9TH0) Headlines

No Headlines